Dementia Research Today is a free monthly online journal that collates and summarizes the latest research about Dementia, including details on symptoms, alzheimers, senile dementia, causes.

Volume 1 (2004), Issue 4 (November)

1. Immunolocalization of 14-3-3 isoforms in brains with Pick body disease.
   Neurosci Lett, 371(2): 215-9. [Abstract] [Full-text]
2. Plasminogen activities and concentrations in patients with sporadic Creutzfeldt-Jakob disease.
   Neurosci Lett, 371(2): 163-6. [Abstract] [Full-text]
3. Analysis of association between butyrylcholinesterase K variant and apolipoprotein E genotypes in Alzheimer's disease.
   Neurosci Lett, 371(2): 142-6. [Abstract] [Full-text]
4. Alzheimer's beta-peptide oligomer formation at physiologic concentrations.
   Anal Biochem, 335(1): 81-90. [Abstract] [Full-text]
5. Dementia of Alzheimer's disease and other neurodegenerative disorders--memantine, a new hope.
   Pharmacol Res, 51(1): 1-17. [Abstract] [Full-text]
6. Small de novo duplication in the repeat region of the TATA-box-binding protein gene manifest with a phenotype similar to variant Creutzfeldt-Jakob disease.
   Clin Genet, 66(6): 496-501. [Abstract] [Full-text]
7. Effects of rivastigmine on motor and cognitive impairment in Huntington's disease.
   Mov Disord, 19(12): 1516-8. [Abstract] [Full-text]
8. Association of the HTR6 polymorphism C267T with late-onset Alzheimer's disease in Chinese.
   Neurosci Lett, 372(1): 27-9. [Abstract] [Full-text]
9. Upregulation of amyloid precursor protein isoforms containing Kunitz protease inhibitor in dementia with Lewy bodies.
   Brain Res Mol Brain Res, 131(1): 131-5. [Abstract] [Full-text]
10. Allele-specific overexpression in astrocytes of an Alzheimer's disease associated alpha-1-antichymotrypsin promoter polymorphism.
    Brain Res Mol Brain Res, 131(1): 88-92. [Abstract] [Full-text]
11. Transferrin neutralization of amyloid beta 25-35 cytotoxicity.
    Clin Chim Acta, 350(1): 129-36. [Abstract] [Full-text]
12. Abeta N-terminal-end specific antibody reduced beta-amyloid in Alzheimer-model mice.
    Biochem Biophys Res Commun, 325(2): 384-7. [Abstract] [Full-text]
13. Driving and dementia: a review of the literature.
    J Geriatr Psychiatry Neurol, 17(4): 232-40. [Abstract] [Full-text]
14. Serum levels of soluble intercellular adhesion molecule-1 and soluble endothelial leukocyte adhesion molecule-1 in Alzheimer's disease.
    J Geriatr Psychiatry Neurol, 17(4): 225-31. [Abstract] [Full-text]
15. Neuropsychosocial features of very mild Alzheimer's disease (CDR 0.5) and progression to dementia in a community: the Tajiri project.
    J Geriatr Psychiatry Neurol, 17(4): 183-9. [Abstract] [Full-text]
16. Investigation of profile difference between Alzheimer's disease patients declining at different rates: examination of baseline neuropsychological data.
    Arch Clin Neuropsychol, 19(8): 1007-15. [Abstract] [Full-text]
17. Statins lower the risk of developing Alzheimer's disease by limiting lipid raft endocytosis and decreasing the neuronal spread of Herpes simplex virus type 1.
    Med Hypotheses, 64(1): 53-8. [Abstract] [Full-text]
18. An antiaggregation gene therapy strategy for Lewy body disease utilizing beta-synuclein lentivirus in a transgenic model.
    Gene Ther, 11(23): 1713-23. [Abstract] [Full-text]
19. Involvement of alpha6/alpha3 neuronal nicotinic acetylcholine receptors in neuropsychiatric features of Dementia with Lewy bodies: [(125)I]-alpha-conotoxin MII binding in the thalamus and striatum.
    Neurosci Lett, 372(3): 220-5. [Abstract] [Full-text]
20. A deletion in DJ-1 and the risk of dementia--a population-based survey.
    Neurosci Lett, 372(3): 196-9. [Abstract] [Full-text]
21. Metal-mediated formation of fibrillar ABri amyloid.
    J Inorg Biochem, 98(12): 2006-10. [Abstract] [Full-text]
22. Ballooned neurones in the limbic lobe are associated with Alzheimer type pathology and lack diagnostic specificity.
    Neuropathol Appl Neurobiol, 30(6): 676-82. [Abstract] [Full-text]
23. Differential expression of alpha-synuclein isoforms in dementia with Lewy bodies.
    Neuropathol Appl Neurobiol, 30(6): 601-7. [Abstract] [Full-text]
24. Alzheimer's disease Abeta peptide fragment 10-30 forms a spectrum of metastable oligomers with marked preference for N to N and C to C monomer termini proximity.
    J Mol Biol, 344(4): 1037-49. [Abstract] [Full-text]
25. Longitudinal analysis of nef/long terminal repeat-deleted HIV-1 in blood and cerebrospinal fluid of a long-term survivor who developed HIV-associated dementia.
    J Infect Dis, 190(12): 2181-6. [Abstract] [Full-text]
26. Psychosocial work factors and dementia.
    Occup Environ Med, 61(12): 962-71. [Abstract] [Full-text]
27. Polymorphisms in neprilysin gene affect the risk of Alzheimer's disease in Finnish patients.
    J Neurol Neurosurg Psychiatry, 75(12): 1746-8. [Abstract] [Full-text]
28. Similar early clinical presentations in familial and non-familial frontotemporal dementia.
    J Neurol Neurosurg Psychiatry, 75(12): 1743-5. [Abstract] [Full-text]
29. Neurosyphilis in the modern era.
    J Neurol Neurosurg Psychiatry, 75(12): 1727-30. [Abstract] [Full-text]
30. Apolipoprotein E genotypes do not influence the age of onset in Huntington's disease.
    J Neurol Neurosurg Psychiatry, 75(12): 1692-6. [Abstract] [Full-text]
31. Does the risk of developing dementia increase with the number of episodes in patients with depressive disorder and in patients with bipolar disorder?
    J Neurol Neurosurg Psychiatry, 75(12): 1662-6. [Abstract] [Full-text]
32. Plasma homocysteine, vitamin B12 and folate in Alzheimer's patients and healthy Arabs in Israel.
    J Neurol Sci, 227(1): 109-13. [Abstract] [Full-text]
33. New tools for preimplantation genetic diagnosis of Huntington's disease and their clinical applications.
    Eur J Hum Genet, 12(12): 1007-14. [Abstract] [Full-text]
34. Loss of glycosylation associated with the T183A mutation in human prion disease.
    Acta Neuropathol (Berl), 108(6): 476-84. [Abstract] [Full-text]
35. Glycogen synthase kinase-3 is increased in white cells early in Alzheimer's disease.
    Neurosci Lett, 373(1): 1-4. [Abstract] [Full-text]
36. Depression in older persons with versus without vascular disease in the open population: similar depressive symptom patterns, more disability.
    J Affect Disord, 83(2): 155-60. [Abstract] [Full-text]
37. GSK-3 phosphorylation of the Alzheimer epitope within collapsin response mediator proteins regulates axon elongation in primary neurons.
    J Biol Chem, 279(48): 50176-80. [Abstract] [Full-text]
38. Regional and cellular pathology in frontotemporal dementia: relationship to stage of disease in cases with and without Pick bodies.
    Acta Neuropathol (Berl), 108(6): 515-23. [Abstract] [Full-text]
39. An autopsy case of hereditary diffuse leukoencephalopathy with spheroids, clinically suspected of Alzheimer's disease.
    Acta Neuropathol (Berl), 108(6): 538-45. [Abstract] [Full-text]
40. Endothelin-converting enzyme-1 is expressed in human cerebral cortex and protects against Alzheimer's disease.
    Mol Psychiatry, 9(12): 1122-8, 1059. [Abstract] [Full-text]
41. Variations in estrogen receptor alpha gene and risk of dementia, and brain volumes on MRI.
    Mol Psychiatry, 9(12): 1129-35. [Abstract] [Full-text]
42. Fibrillar amyloid-beta peptides kill human primary neurons via NADPH oxidase-mediated activation of neutral sphingomyelinase. Implications for Alzheimer's disease.
    J Biol Chem, 279(49): 51451-9. [Abstract] [Full-text]
43. NF-kappaB precursor, p105, and NF-kappaB inhibitor, IkappaBgamma, are both elevated in Alzheimer disease brain.
    Neurosci Lett, 373(2): 115-8. [Abstract] [Full-text]
44. Double-strand RNA dependent protein kinase (PKR) is involved in the extrastriatal degeneration in Parkinson's disease and Huntington's disease.
    Neurochem Int, 46(1): 11-8. [Abstract] [Full-text]
45. Immunohistochemical study of hnRNP B1 in the postmortem temporal cortices of patients with Alzheimer's disease.
    Neurosci Res, 50(4): 481-4. [Abstract] [Full-text]
46. In vivo detection of microglial activation in frontotemporal dementia.
    Ann Neurol, 56(6): 894-7. [Abstract] [Full-text]
47. Astrocyte specific viral strains in HIV dementia.
    Ann Neurol, 56(6): 873-7. [Abstract] [Full-text]
48. Increased GABAergic function in mouse models of Huntington's disease: reversal by BDNF.
    J Neurosci Res, 78(6): 855-67. [Abstract] [Full-text]

© 2004-2008 Dementia Research Today. All Rights Reserved.